Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 11, 1997

View Archived Issues

Spiro compounds for CNS disorders disclosed by Takeda

U.S. and European investigators describe agents for CNS disorders

ET antagonists reported by Japanese investigators

Takeda prepares NO production inhibitors

Sankyo develops antidiabetic agents

Eisai synthesizes heterocyclic anticancer compounds

Hypoglycemic/hypolipidemic agents from Kyorin

Sumitomo develops ACAT inhibitors

Diagnostic MAbs from Terumo

Update on GEM-91

Potent gpIIb/IIIa antagonist synthesized using combinatorial techniques

U.S. patent issued for meningococcal B vaccine

Selective gelatinase inhibitor described by British Biotech

Tanabe selects ellipticine derivative for further development

Potent dual CCK-A/CCK-B antagonist discovered by Japanese researchers

Genzyme Transgenics reports advances in transgenic production of MAbs

Merck & Co. and Costa Rican institute renew biological diversity agreement

U.S. researchers report significant advance in gene therapy for hearing disorders

ChemTrak colorectal cancer home test ready for launch

Essential fatty acids in schizophrenia

Cangene awarded ISO registration

Remune associated with chemokine induction

U.K. launch for SKB anticancer treatment

Positive phase III trials results for citicoline

Tretinoin gel cleared for marketing by FDA

T Cell Sciences awarded second grant for vaccine development

Sparta expands clinical trials of retinoid

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...